Bionano Genomics Inc BNGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BNGO is a good fit for your portfolio.
News
-
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
-
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
-
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
-
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
-
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
-
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
-
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting
Trading Information
- Previous Close Price
- $0.88
- Day Range
- $0.89–0.98
- 52-Week Range
- $0.71–8.20
- Bid/Ask
- $0.98 / $0.98
- Market Cap
- $58.69 Mil
- Volume/Avg
- 11,015 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.91
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 344
- Website
- https://www.bionano.com
Comparables
Valuation
|
Metric
|
BNGO
|
TIHE
|
NAUT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.46 | — | 1.39 |
Price/Sales | 0.91 | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNGO
|
TIHE
|
NAUT
|
|---|---|---|---|
Quick Ratio | 1.12 | — | 19.01 |
Current Ratio | 1.40 | — | 19.39 |
Interest Coverage | −45.05 | — | — |
Quick Ratio
BNGO
TIHE
NAUT
Profitability
|
Metric
|
BNGO
|
TIHE
|
NAUT
|
|---|---|---|---|
Return on Assets (Normalized) | −50.51% | — | −15.61% |
Return on Equity (Normalized) | −70.28% | — | −17.76% |
Return on Invested Capital (Normalized) | −61.23% | — | −19.72% |
Return on Assets
BNGO
TIHE
NAUT
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Cgjbscqjmq | Llnnf | $131.8 Bil | |
BDX
| Becton Dickinson & Co | Lhshgtwk | Yybjxf | $67.5 Bil | |
ALC
| Alcon Inc | Qqtpyppp | Wtsqrb | $38.1 Bil | |
RMD
| ResMed Inc | Kjcywhqsc | Rqhqvg | $31.6 Bil | |
CLPBY
| Coloplast A/S ADR | Jyszzhws | Cryz | $26.9 Bil | |
WST
| West Pharmaceutical Services Inc | Qxqdwfxh | Mtww | $26.6 Bil | |
BAX
| Baxter International Inc | Swnplrnk | Mlylvp | $20.5 Bil | |
HOLX
| Hologic Inc | Prsyktqv | Htwpjbn | $17.9 Bil | |
COO
| The Cooper Companies Inc | Nvhwmpz | Grkztc | $17.8 Bil | |
TFX
| Teleflex Inc | Dkybp | Ypj | $10.0 Bil |